Literature DB >> 8592218

Early postoperative magnetic resonance imaging following nonneoplastic cortical resection.

M M Henegar1, C J Moran, D L Silbergeld.   

Abstract

Postcraniotomy residual tumor is often determined by magnetic resonance (MR) imaging. Magnetic resonance changes that occur in the postoperative setting must be defined to ensure both the optimum timing of postoperative image acquisition and the accurate assessment of images for residual tumor. Postoperative changes in nontumor parenchyma have previously been described for computerized tomography but not for MR imaging. In the present study, 11 patients without intracranial neoplastic disease (six females and five males with a median age of 36 years) submitted to MR imaging 17 to 28 hours after undergoing temporal lobectomies for epilepsy. Four of the operations were performed with the patients under general anesthesia and seven under local anesthesia. Postoperative MR images (T1-weighted, T1-weighted gadolinium enhanced, and T2-weighted) were reviewed. Extraaxial fluid, air, or blood was present in all cases. Enhancement of the resection bed parenchyma occurred in seven (64%) of 11 patients. In three of the remaining four patients, assessment of parenchymal enhancement was obscured by extraaxial fluid collections. Dural enhancement occurred adjacent to the resection site in all of the cases and remotely in 73%. Eight (73%) of 11 patients displayed enhancement of the pia-arachnoid of the ipsilateral cerebral convexity, two (18%) of the contralateral convexity, and four (36%) of the pia-arachnoid overlying the cerebellum. Contrary to previous reports, contrast enhancement of nonneoplastic human brain parenchyma can occur postoperatively within 17 hours. Benign parenchymal contrast enhancement is usually linear in appearance; nonneoplastic dural and leptomeningeal enhancement can occur both adjacent to and distant from the surgical site. Extraaxial fluid collections can hinder MR evaluation of the resection bed.

Entities:  

Mesh:

Year:  1996        PMID: 8592218     DOI: 10.3171/jns.1996.84.2.0174

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  30 in total

1.  Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging.

Authors:  M Knauth; N Aras; C R Wirtz; A Dörfler; T Engelhorn; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  Choroid plexus changes after temporal lobectomy.

Authors:  S Saluja; N Sato; Y Kawamura; W Coughlin; C M Putman; D D Spencer; G Sze; R A Bronen
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

3.  Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria.

Authors:  Alexander Radbruch; Kira Lutz; Benedikt Wiestler; Philipp Bäumer; Sabine Heiland; Wolfgang Wick; Martin Bendszus
Journal:  Neuro Oncol       Date:  2011-12-06       Impact factor: 12.300

4.  MRI and thallium-201 SPECT in the prediction of survival in glioma.

Authors:  Maaike J Vos; Johannes Berkhof; Otto S Hoekstra; Ingeborg Bosma; Eefje M Sizoo; Jan J Heimans; Jaap C Reijneveld; Esther Sanchez; Frank J Lagerwaard; Jan Buter; David P Noske; Tjeerd J Postma
Journal:  Neuroradiology       Date:  2011-07-14       Impact factor: 2.804

5.  Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.

Authors:  Andrea Pirzkall; Colleen McGue; Suja Saraswathy; Soonmee Cha; Raymond Liu; Scott Vandenberg; Kathleen R Lamborn; Mitchel S Berger; Susan M Chang; Sarah J Nelson
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

6.  Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD).

Authors:  Patrick Y Wen; Timothy F Cloughesy; Benjamin M Ellingson; David A Reardon; Howard A Fine; Lauren Abrey; Karla Ballman; Martin Bendszuz; Jan Buckner; Susan M Chang; Michael D Prados; Whitney B Pope; Alma Gregory Sorensen; Martin van den Bent; Wai-Kwan Alfred Yung
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

7.  Independent Poor Prognostic Factors for True Progression after Radiation Therapy and Concomitant Temozolomide in Patients with Glioblastoma: Subependymal Enhancement and Low ADC Value.

Authors:  R-E Yoo; S H Choi; T M Kim; S-H Lee; C-K Park; S-H Park; I H Kim; T J Yun; J-H Kim; C H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

8.  Spurious leptomeningeal enhancement on immediate post-operative MRI for paediatric brain tumours.

Authors:  Elysa Widjaja; Daniel J A Connolly; Sylvia Gatscher; John McMullen; Paul D Griffiths
Journal:  Pediatr Radiol       Date:  2004-11-13

Review 9.  Cutting-edge imaging of the spine.

Authors:  A Talia Vertinsky; Michael V Krasnokutsky; Michael Augustin; Roland Bammer
Journal:  Neuroimaging Clin N Am       Date:  2007-02       Impact factor: 2.264

10.  End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.

Authors:  Martin J van den Bent; Michael A Vogelbaum; Patrick Y Wen; David R Macdonald; Susan M Chang
Journal:  J Clin Oncol       Date:  2009-05-18       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.